Stockhub

Public Joint-Stock Company "Human Stem Cells Institute": Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 September 2022

  • curprev 18:4218:42, 21 September 2022 95.149.241.133 talk 2,057 bytes +2,057 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Public Joint-Stock Company ‘Human Stem Cells Institute' operates as a biotech company primarily in Russia. The company engages in the drug discovery, research and development, and marketing of proprietary products and services in the field of regenerative medicine; bio-insurance; medical genetics, including reproductive genetics; gene therapy; and biopharmaceutics. It owns and operates Gemabank, a family cord blood stem ce..."
Retrieved from "https://stockhub.co/research/Public_Joint-Stock_Company_%22Human_Stem_Cells_Institute%22"